Masatsugu Ohta

Fukushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Methotrexate, Hydrocortisone, Vincristine, Sobuzoxane, and Etoposide Is an Effective Option for Relapsed T-cell Prolymphocytic Leukemia with Loss of CD52 Expression after Retreatment with Alemtuzumab.

Methotrexate, Hydrocortisone, Vincristine, Sobuzoxane, and Etoposide Is an Effective Option for Relapsed T-cell Prolymphocytic Leukemia with Loss of CD52 Expression after Retreatment with Alemtuzumab.

Journal: JMA journal

Published: July 01, 2024

Dynamic changes in femoral bone marrow MRI in patients with chronic myelogenous leukemia.

Dynamic changes in femoral bone marrow MRI in patients with chronic myelogenous leukemia.

Journal: International journal of hematology

Published: February 09, 2024

Bleeding Risk of Acupuncture for Patients with Hematological Malignancies Accompanying Thrombocytopenia: A Retrospective Chart Review.

Bleeding Risk of Acupuncture for Patients with Hematological Malignancies Accompanying Thrombocytopenia: A Retrospective Chart Review.

Journal: Journal of integrative and complementary medicine

Published: July 05, 2023

MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.

MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: February 08, 2021

Femoral marrow MRI is a non-invasive, non-irradiated and useful tool for detecting bone marrow involvement in non-Hodgkin lymphoma.

Femoral marrow MRI is a non-invasive, non-irradiated and useful tool for detecting bone marrow involvement in non-Hodgkin lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: February 08, 2021

AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells.

AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells.

Journal: Cancer science

Published: June 09, 2020

The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study.

The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study.

Journal: Annals of hematology

Published: November 20, 2019

Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.

Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.

Journal: Cancer science

Published: February 07, 2018

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Journal: American journal of hematology

Published: August 24, 2017

The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p.

The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p.

Journal: Leukemia research

Published: November 21, 2016

Treatment of leukemia in senior adults

Treatment of leukemia in senior adults

Journal: Nihon rinsho. Japanese journal of clinical medicine

Published: November 09, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026